Valuation: Medico Remedies Limited

Market Cap 1.55B 16.64M 15.1M 13.95M 12.59M 23.76M 24.67M 168M 66.49M 839M 62.42M 61.1M 2.65B P/E 2025
42.8x
P/E 2026 20.7x
Enterprise Value 1.71B 18.3M 16.61M 15.34M 13.84M 26.13M 27.13M 185M 73.13M 922M 68.65M 67.2M 2.91B EV / Sales 2025
2.94x
EV / Sales 2026 1.39x
Free-Float
31.79%
Yield 2025 *
-
Yield 2026 -
1 day-2.56%
1 week-3.29%
Current month-2.14%
1 month-14.28%
3 months-57.30%
6 months-59.08%
Current year-63.90%
1 week 17.72
Extreme 17.72
19.34
1 month 17.72
Extreme 17.72
23.39
Current year 17.72
Extreme 17.72
56.99
1 year 17.72
Extreme 17.72
56.99
3 years 17.72
Extreme 17.72
92.87
5 years 15.11
Extreme 15.11
100.79
10 years 3.35
Extreme 3.35
100.79
Manager TitleAgeSince
Chief Executive Officer 41 15/09/2017
Director of Finance/CFO 71 15/09/2017
Compliance Officer - 18/02/2026
Director TitleAgeSince
Chairman 71 18/03/1994
Director/Board Member 41 14/12/2011
Director/Board Member 66 15/09/2017
Date Insider Type Main position Quantity % Market Cap. Importance
12/5/24 A Sell

Director

1,400,000 1.6871%
12/5/24 A Sell

Director

400,000 0.4820%
11/20/24 A Sell

General Counsel

900,000 1.0845%
Change 5-day change 1-year change 3-year change Capi.($)
-2.56%-3.29%-64.82%-76.28% 16.64M
-1.13%-1.17%+38.55%+139.23% 1,261B
-1.36%-0.74%+39.64%+86.06% 671B
-0.59%-0.36%+25.14%+111.73% 518B
-0.01%+0.95%+32.28%+71.07% 387B
-0.75%-3.16%+54.39%+40.90% 353B
-0.44%-0.14%+29.96%+57.29% 300B
-0.64%-1.55%+0.84%+35.37% 283B
-0.95%-1.57%+34.01%+72.55% 248B
+1.60%-0.36%+37.21%+125.66% 211B
Average -0.64%-0.66%+22.72%+66.36% 423B
Weighted average by Cap. -0.36%-0.55%+34.37%+95.66%

Financials

2025 2026
Net sales 1.51B 16.16M 14.67M 13.55M 12.22M 23.07M 23.96M 163M 64.57M 814M 60.61M 59.34M 2.57B 2.06B 22.09M 20.05M 18.52M 16.71M 31.55M 32.76M 223M 88.28M 1.11B 82.87M 81.13M 3.52B
Net income 101M 1.08M 981K 906K 817K 1.54M 1.6M 10.92M 4.32M 54.46M 4.05M 3.97M 172M 131M 1.4M 1.27M 1.18M 1.06M 2M 2.08M 14.18M 5.61M 70.77M 5.27M 5.16M 224M
Net Debt 122M 1.3M 1.18M 1.09M 984K 1.86M 1.93M 13.14M 5.2M 65.58M 4.88M 4.78M 207M 155M 1.66M 1.51M 1.39M 1.26M 2.37M 2.46M 16.79M 6.64M 83.78M 6.23M 6.1M 265M
Projected Income Statement - Annual - Medico Remedies Limited
Logo Medico Remedies Limited
Medico Remedies Limited is an India-based company, principally engaged in the pharmaceutical business. The Company is involved in the development, manufacture and sale of pharmaceutical and nutraceutical products. It focuses on anti-infective, Beta-Lactams, cephalosporins, antimalarial, antiretroviral, anti-ulcer drugs and antacids, vitamins, hematinic and other supplements. The Company also manufactures and markets capabilities in other drugs such as non-steroidal anti-inflammatory drugs (NSAIDS), antihistaminic, anti-diabetics, cardiovascular drugs, diuretics, anti-epileptics, combination drug kits, syrups and cream and gel for various therapeutic segments. Its products include Doxycycline Capsules, Zenof-400 (Ofloxacin Tablets 400mg), Azithromycin Tablets, Aciclovir Tablets, Cipta Tablets, Cotrimoxazole Tablets, Tos Syrup, Pediatric Co-Trimozole Oral, Med Reactin (Cyproheptadine), and Medivit Syrup, among others. Its syrups include Medivit Syrup and Ferrovit Syrup.
Employees
105
Date Price Change Volume
18/11/26 ₹18.25 -2.56% 25,589
17/11/26 ₹18.73 +2.02% 28,497
16/11/26 ₹18.36 -0.70% 8,442
13/11/26 ₹18.49 -2.12% 20,217
12/11/26 ₹18.89 +0.11% 15,755
  1. Stock Market
  2. Stocks
  3. MEDICO Stock